Evidence map›Paper›PMID 29796324›Full record

ArticleCase reports in endocrinology2018

A Case of Pneumothorax after Treatment with Lenvatinib for Anaplastic Thyroid Cancer with Lung Metastasis.

Haruhiko Yamazaki, Hiroyuki Iwasaki, Toshinari Yamashita, Tatsuya Yoshida, Nobuyasu Suganuma, Takashi Yamanaka, Katsuhiko Masudo, Hirotaka Nakayama, Kaori Kohagura, Yasushi Rino and 1 more

Abstract readCase Reports
In one paragraph

Article in Case reports in endocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Thyroid metastasis from non-small cell lung cancer.International journal of clinical and experimental pathology · 2019
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Haruhiko YamazakiDepartment of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama, Japan.ORCID 0000-0002-6640-3529
Hiroyuki IwasakiDepartment of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Toshinari YamashitaDepartment of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Tatsuya YoshidaDepartment of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Nobuyasu SuganumaDepartment of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Takashi YamanakaDepartment of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Katsuhiko MasudoDepartment of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan.
Hirotaka NakayamaDepartment of Surgery, Yokohama City University School of Medicine, Yokohama, Japan.
Kaori KohaguraDepartment of Surgery, Yokohama City University School of Medicine, Yokohama, Japan.
Yasushi RinoDepartment of Surgery, Yokohama City University School of Medicine, Yokohama, Japan.
Munetaka MasudaDepartment of Surgery, Yokohama City University School of Medicine, Yokohama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 63-year-old man was diagnosed with multiple lung metastases from anaplastic thyroid cancer and received lenvatinib. Follow-up computed tomography on day 34 of lenvatinib treatment showed pneumothorax. The pneumothorax was temporarily improved with chest drainage. However, pleurodesis was performed to treat a relapse of the pneumothorax. Pneumothorax during chemotherapy for a malignant tumor is considered a relatively rare complication. This case is the first documentation that pneumothorax may develop during lenvatinib treatment. The possible development of pneumothorax should be considered when lenvatinib is used in patients with lung metastasis.

Identifiers

PMID29796324
PMCPMC5896288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.